월요일, 3월 23, 2026
HomeWomen's HealthManeesha Ghiya Talks Femtech and the Way forward for Ladies’s Healthcare

Maneesha Ghiya Talks Femtech and the Way forward for Ladies’s Healthcare



In terms of improvements in healthcare, Maneesha Ghiya means enterprise.

As a enterprise capitalist and investor at hedge funds, the Harvard Enterprise grad has spent greater than 25 years — just about her whole profession — investing in healthcare.

However when a medical emergency virtually took her life, Ghiya noticed firsthand the necessity for innovation in girls’s healthcare particularly. So, she began her personal enterprise capital agency, FemHealth Ventures, to fill that hole.

FemHealth Ventures companions with companies to advance girls’s well being via drugs, gadgets, digital and synthetic intelligence, and diagnostics (imaging, checks and instruments).

The agency’s funding method seems to be at girls’s well being circumstances in 3 ways: “Solely girls” (endometriosis), “largely girls” (breast most cancers) and “otherwise in girls” (coronary heart illness).

“We created and printed this framework in 2019, and it has since been adopted by many others throughout the healthcare business. By defining girls’s well being extra broadly, we’re capable of establish and produce ahead improvements that handle circumstances throughout girls’s well being,” Ghiya stated.

We requested Ghiya for her ideas on the technology-based options which are making waves in girls’s well being, and the way her personal well being scare impressed her ardour for change.

Our interview follows, edited for readability and size.

HealthyWomen: Inform us about your expertise with postpartum hemorrhage and the way it led to the launch of FemHealth Ventures?

Maneesha Ghiya: Once I gave beginning to my daughter at Columbia College underneath the care of a prime OB-GYN, I encountered critical problems.

What started as an emergency C-section was a disaster with an undetected inside bleed. 4 surgeons carried out a reoperation that was in the end unsuccessful in finding the supply, and I used to be transferred to the ICU, the place I underwent 10 transfusions of blood and platelets.

Happily, my physique caught up with the bleed, and I survived. However that ordeal fueled a want for me to make a distinction in girls’s well being, which led me to discovered FemHealth Ventures.

Learn: Postpartum Hemorrhage Is a Lethal Downside >>

HW: Traditionally, we all know that ladies’s well being has been missed and underfunded. How is femtech serving to to broaden curiosity in girls’s well being?

Ghiya: We put money into medication, gadgets, diagnostics, and digital and synthetic intelligence within the girls’s well being area. We contemplate femtech a subset of girls’s well being and would see any software program or AI platforms tailor-made in direction of girls’s well being falling into our digital and AI funding focus.

For instance, we invested in an organization referred to as Cercle AI. Its product analyzes affected person data inside a fertility clinic, permitting medical doctors to rapidly entry knowledge on how related circumstances had been handled, together with protocols, success charges and uncomfortable side effects.

This helps optimize remedy plans, resulting in larger success charges — which, for these conversant in the IVF journey, is extremely impactful.

Learn: Infertility Isn’t Only a Bodily Journey — It’s an Emotional One, Too >>

HW: What are you discovering most enjoyable on the planet of femtech proper now?

Ghiya: I’m excited to see how AI and robotics can elevate the usual of care throughout medical facilities.

One thrilling utility we see within the robotics and AI class is for needle-based procedures. For example, contemplate epidurals throughout labor — 1 in 10 both fail or want adjustment as a result of every individual has a unique anatomy, which makes it difficult even for consultants to realize exact needle placement.

Certainly one of our portfolio corporations, Mendaera, has created a robotic needle-guidance gadget that mixes ultrasound imaging with robotic supply.

Past epidurals, this expertise will be utilized to procedures like nerve blocks and breast biopsies. This can be a recreation changer as a result of, beforehand, solely extremely expert clinicians might carry out some of these procedures with effectivity and accuracy. With this robotic and AI steering system, extra clinicians can ship needle-based care extra exactly, which is extremely impactful for sufferers who might not have entry to main medical facilities.

HW: Since launching FemHealth Ventures, inform us a couple of product/innovation that has been significantly memorable for you.

Ghiya: We had been very excited when our portfolio firm Gynesonics was acquired in January by Hologic. At present, greater than 200,000 girls within the U.S. bear hysterectomies annually as a result of extreme and infrequently debilitating signs of fibroids.

Gynesonics provides a brand new resolution: a non-surgical, outpatient process utilizing radiofrequency ablation. The process is incision-free, permitting girls to return to work as quickly as the following day — in comparison with the months-long restoration related to surgical procedure. Because of Gynesonics, a whole lot of hundreds of girls will keep away from hysterectomies. It was thrilling to see this wonderful innovation be delivered to extra girls via this acquisition.

HW: What large developments are you hoping to see in girls’s healthcare within the close to future, or what ought to we’ve on our radar?

Ghiya: I’m excited to see extra options for girls within the postpartum despair (PPD) area. Sadly, maternal mortality charges within the U.S. have been on the rise in recent times, with PPD being a major contributor. In response to this pressing want, we invested in Reunion Neurosciences, which is growing a breakthrough drug remedy to handle PPD.

It entails a one-time, four-hour remedy administered in a specialised facility by skilled medical professionals [and has shown promising results in clinical trials]. The drug remedy is at present present process a full FDA trial and approval course of and can solely be accessible underneath medical supervision.

Learn: When Postpartum Melancholy Hit, I Heard Solely the Lies My Melancholy Instructed Me >>

HW: What’s your recommendation for a way readers might help assist improvements in femtech?

Ghiya: We encourage anybody occupied with supporting girls’s well being to remain knowledgeable.

My firm frequently posts articles on our LinkedIn about key updates within the girls’s well being area and updates from our girls’s well being targeted portfolio corporations. An ideal instance of a current replace within the girls’s well being area is the Gates Basis pledging $2.5 billion to girls’s well being initiatives. We’re thrilled to see the rising focus and momentum within the girls’s well being area.

From Your Website Articles

Associated Articles Across the Net

RELATED ARTICLES
RELATED ARTICLES

Most Popular